Skip to main content

Tarsus Pharmaceuticals, Inc 10-Q for FY2025 Q1

Tarsus Pharmaceuticals, Inc. (TARS)

10-Q 2025-05-01 For: 2025-03-31
View Original
Added on April 04, 2026

About this 10-Q

Tarsus Pharmaceuticals, Inc filed this 10-Q on May 1, 2025, covering the quarter ended March 31, 2025 (FY2025 Q1).

Headline figures

Quarter ended March 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$78.34M
up 183.7% from $27.61M a year earlier
Net loss
$25.12M
compared with a net loss of $35.73M a year earlier
Diluted EPS
-$0.64
compared with -$1.01 a year earlier